Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126187351 | 12618735 | 1 | I | 2014 | 20160721 | 20160803 | 20160803 | EXP | NL-JNJFOC-20160718912 | JANSSEN | 0.00 | E | M | Y | 0.00000 | 20160803 | MD | NL | NL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126187351 | 12618735 | 1 | SS | ABIRATERONE | ABIRATERONE | 1 | Oral | Y | N | 0 | 1000 | MG | TABLET | QD | |||||
| 126187351 | 12618735 | 2 | PS | ABIRATERONE | ABIRATERONE | 1 | Oral | Y | N | 202379 | 1000 | MG | TABLET | QD | |||||
| 126187351 | 12618735 | 3 | SS | FENTANYL. | FENTANYL | 1 | Unknown | Y | N | 0 | MATRIX PATCH | ||||||||
| 126187351 | 12618735 | 4 | SS | FENTANYL. | FENTANYL | 1 | Unknown | Y | N | 0 | MATRIX PATCH | ||||||||
| 126187351 | 12618735 | 5 | SS | FENTANYL. | FENTANYL | 1 | Unknown | Y | N | 0 | MATRIX PATCH | ||||||||
| 126187351 | 12618735 | 6 | SS | FENTANYL. | FENTANYL | 1 | Unknown | Y | N | 19813 | MATRIX PATCH | ||||||||
| 126187351 | 12618735 | 7 | C | CYPROTERONE | CYPROTERONE | 1 | Unknown | 0 | 50 | MG | UNKNOWN | QD | |||||||
| 126187351 | 12618735 | 8 | C | HYDROMORPHONE | HYDROMORPHONE | 1 | Unknown | 0 | 1.3 | MG | CAPSULE | ||||||||
| 126187351 | 12618735 | 9 | C | MACROGOL | POLYETHYLENE GLYCOLS | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 126187351 | 12618735 | 10 | C | BISACODYL. | BISACODYL | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 126187351 | 12618735 | 11 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | Unknown | 0 | 10 | MG | UNSPECIFIED | TID | |||||||
| 126187351 | 12618735 | 12 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | 0 | 20 | MG | UNSPECIFIED | QD | |||||||
| 126187351 | 12618735 | 13 | C | OXAZEPAM. | OXAZEPAM | 1 | Unknown | 0 | 10 | MG | UNSPECIFIED | QD | |||||||
| 126187351 | 12618735 | 14 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | 0 | 5 | MG | UNSPECIFIED | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126187351 | 12618735 | 1 | Hormone-refractory prostate cancer |
| 126187351 | 12618735 | 2 | Hormone-refractory prostate cancer |
| 126187351 | 12618735 | 3 | Pain |
| 126187351 | 12618735 | 4 | Pain |
| 126187351 | 12618735 | 5 | Pain |
| 126187351 | 12618735 | 6 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126187351 | 12618735 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126187351 | 12618735 | Nausea | |
| 126187351 | 12618735 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126187351 | 12618735 | 1 | 20140720 | 20140722 | 0 | |
| 126187351 | 12618735 | 2 | 20140628 | 20140716 | 0 | |
| 126187351 | 12618735 | 7 | 20140627 | 0 | ||
| 126187351 | 12618735 | 9 | 20140627 | 0 | ||
| 126187351 | 12618735 | 10 | 20140728 | 0 | ||
| 126187351 | 12618735 | 11 | 20140625 | 0 | ||
| 126187351 | 12618735 | 12 | 20140628 | 0 | ||
| 126187351 | 12618735 | 13 | 20140627 | 0 | ||
| 126187351 | 12618735 | 14 | 20130710 | 0 |